Hybio Pharma Surges 20% After Announcing RWA Token Partnership with KuCoin

TradingKey – On Monday, August 4, Chinese pharmaceutical firm Hybio Pharma (SHE: 300199) saw its stock skyrocket 20% intraday, hitting the daily limit before settling around +18%, following news of a strategic partnership with KuCoin, the world’s 9th-largest crypto exchange.

Hybio Pharma Stock Chart – Source: Google

Hybio and KuCoin will co-launch a Real World Asset (RWA) tokenization pilot, focused on the future revenue rights of Hybio’s GLP-1 peptide drug pipeline.

• The token will be backed by Hybio’s proprietary R&D assets, including FDA-approved formulations and next-gen triple receptor agonists
• KuCoin will provide full-stack support: blockchain infrastructure, token issuance, on-chain revenue mapping, and global compliance

This marks China’s first pharmaceutical RWA pilot, aligning with Hong Kong’s evolving virtual asset regulations.